Cancer Care Ontario | Cancer Care Ontario

471 Results

Cancer Treatments

Once a diagnosis is made, and cancer is confirmed, the next step is treatment. There are 3 main ways to treat cancer: surgery, cancer drugs (...

Clinical Trials - Radiation Treatment

Cancer Drug Treatment During COVID-19

Document

[PDF]

Case-by-Case Review Program Treatment Data Template

Guidelines and Advice

Use of Amifostine to Ameliorate the Toxic Effects of Chemotherapy in the Treatment of Cancer

Status: Archived
ID: 12-6

May 2012

Guidelines and Advice

Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma

Status: Archived
ID: 2-10

Sep 2011

Guidelines and Advice

Use of Continuous Infusion Pumps During Radiation Treatment: Recommendation Report (March 2012)

Status: Current
ID: GL-C50-29

Mar 2012

Guidelines and Advice

Use of Irinotecan in the Second-Line Treatment of Metastatic Colorectal Cancer

Status: Archived
ID: 2-16

Sep 2011

Guidelines and Advice

Consensus-based organizational guideline for the planning and delivery of spine stereotactic body radiotherapy treatment in Ontario

Status: Current
ID: GL 21-6

Apr 2023

Guidelines and Advice

Contouring Nomenclature - Recommendation Report (Head and Neck Cancer)

Status: Current
ID: GL-C50-12

Feb 2014

Guidelines and Advice

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline

Status: In-Review
ID: 7-9
Version: 2

Apr 2014

Guidelines and Advice

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

Status: In-Review
ID: GL-END 3-21

Jan 2018

Cancer Treatments

Clinical Trials - Radiation Treatment

Cancer Drug Treatment During COVID-19

Case-by-Case Review Program Treatment Data Template

Use of Amifostine to Ameliorate the Toxic Effects of Chemotherapy in the Treatment of Cancer

Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma

Use of Continuous Infusion Pumps During Radiation Treatment: Recommendation Report (March 2012)

Use of Irinotecan in the Second-Line Treatment of Metastatic Colorectal Cancer

Consensus-based organizational guideline for the planning and delivery of spine stereotactic body radiotherapy treatment in Ontario

Contouring Nomenclature - Recommendation Report (Head and Neck Cancer)

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

Pages